Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T16:22:41.068Z.
Calculation as of: 2026-10-06T16:22:41.068Z.
Quote observation: 2026-10-06T16:17:55.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 451a64ce4da380df6ab4c5027584c6fd3c25ecc0cb3c19eab7daced69cd0f5b9
EARNINGS YIELD
N/A
Market Cap
$34.97M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$33.15M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$32.60M
Earnings Yield
N/A
TTM Avg
0.79%
3Y Avg
0.90%
5Y Avg
0.90%
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Grace Therapeutics, Inc. (GRCE) | $34.58M | N/A | N/A | N/A | N/A |
| Accuray Incorporated (ARAY)vs › | $34.33M | N/A | 0.42% | 0.42% | 1.38% |
| BriaCell Therapeutics Corp. (BCTX)vs › | $34.97M | N/A | N/A | N/A | N/A |
| Elutia Inc (ELUT)vs › | $35.15M | 118.24% | 90.36% | 90.36% | 90.36% |
| QT Imaging Holdings, Inc. (QTI)vs › | $35.66M | N/A | N/A | N/A | N/A |
| DocGo Inc. (DCGO)vs › | $35.92M | N/A | 6.97% | 4.38% | 4.29% |
| Aligos Therapeutics, Inc. (ALGS)vs › | $33.23M | N/A | N/A | N/A | N/A |
| EUDA Health Holdings Limited (EUDA)vs › | $33.15M | N/A | N/A | N/A | N/A |
| Rockwell Medical, Inc. (RMTI)vs › | $32.60M | N/A | 0.79% | 0.90% | 0.90% |
| Elicio Therapeutics, Inc. (ELTX)vs › | $36.61M | N/A | N/A | N/A | N/A |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
